Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Unicycive Therapeutics, Inc. - Common Stock (NQ:UNCY)

4.160 -0.040 (-0.95%)
Streaming Delayed Price Updated: 10:50 AM EDT, Aug 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 63,742
Open 4.170
Bid (Size) 4.140 (1)
Ask (Size) 4.160 (2)
Prev. Close 4.200
Today's Range 4.122 - 4.259
52wk Range 2.833 - 11.00
Shares Outstanding 14,508,063
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Faruqi & Faruqi Reminds Unicycive Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 14, 2025 – UNCY
From Faruqi & Faruqi LLP
Via GlobeNewswire
Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain Officers – UNCY
From Pomerantz LLP
Via GlobeNewswire

Performance

YTD
-47.5%
-47.5%
1 Month
-5.9%
-5.9%
3 Month
-29.1%
-29.1%
6 Month
-26.3%
-26.3%
1 Year
+24.7%
+24.7%

More News

Read More
Kaplan Fox Reminds Unicycive Therapeutics, Inc. (UNCY) Investors of a Securities Class Action Deadline on October 14, 2025
Via TheNewswire.com
Topics Lawsuit
Kaplan Fox Reminds Unicycive Therapeutics, Inc. (UNCY) Investors of a Securities Class Action Deadline on October 14, 2025
Via NewMediaWire
Topics Lawsuit
Investors in Unicycive Therapeutics, Inc. Should Contact Levi & Korsinsky Before October 14, 2025 to Discuss Your Rights - UNCY
Via NewMediaWire
Topics Fraud Lawsuit
Investors in Unicycive Therapeutics, Inc. Should Contact Levi & Korsinsky Before October 14, 2025 to Discuss Your Rights - UNCY
Via TheNewswire.com
Topics Fraud Lawsuit
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) - October 14, 2025 Deadline to Join - Contact Levi & Korsinsky
Via NewMediaWire
Topics Fraud Lawsuit
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) - October 14, 2025 Deadline to Join - Contact Levi & Korsinsky
Via TheNewswire.com
Topics Fraud Lawsuit
UNCY Investors with Large Losses Should Contact Robbins LLP for Information About Leading the Unicycive Therapeutics, Inc. Class Action
From Robbins LLP
Via GlobeNewswire
Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Via NewMediaWire
Topics Fraud Lawsuit
Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Via TheNewswire.com
Topics Fraud Lawsuit
Kaplan Fox Alerts Unicycive Therapeutics, Inc. (UNCY) Investors to a Securities Class Action Lawsuit - Deadline is October 14, 2025
Via NewMediaWire
Topics Lawsuit
Kaplan Fox Alerts Unicycive Therapeutics, Inc. (UNCY) Investors to a Securities Class Action Lawsuit - Deadline is October 14, 2025
Via TheNewswire.com
Topics Lawsuit
Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain Officers – UNCY
From Pomerantz LLP
Via GlobeNewswire
Shareholders of Unicycive Therapeutics, Inc. Should Contact Levi & Korsinsky Before October 14, 2025 to Discuss Your Rights - UNCY
Via NewMediaWire
Topics Fraud Lawsuit
Shareholders of Unicycive Therapeutics, Inc. Should Contact Levi & Korsinsky Before October 14, 2025 to Discuss Your Rights - UNCY
Via TheNewswire.com
Topics Fraud Lawsuit
UNICYCIVE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Unicycive Therapeutics, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Kaplan Fox Reminds Unicycive Therapeutics, Inc. (UNCY) Investors of a Securities Class Action Deadline on October 14, 2025
Via NewMediaWire
Topics Lawsuit
Kaplan Fox Reminds Unicycive Therapeutics, Inc. (UNCY) Investors of a Securities Class Action Deadline on October 14, 2025
Via TheNewswire.com
Topics Lawsuit
Kaplan Fox Encourages Investors of Unicycive Therapeutics, Inc. (UNCY) to Contact the Firm Before Lead Plaintiff Deadline on October 14, 2025
Via TheNewswire.com
Topics Lawsuit
Kaplan Fox Encourages Investors of Unicycive Therapeutics, Inc. (UNCY) to Contact the Firm Before Lead Plaintiff Deadline on October 14, 2025
Via NewMediaWire
Topics Lawsuit
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics
From Faruqi & Faruqi LLP
Via GlobeNewswire
October 14, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against UNCY
Via NewMediaWire
Topics Fraud Lawsuit
October 14, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against UNCY
Via TheNewswire.com
Topics Fraud Lawsuit
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc. - UNCY
From Pomerantz LLP
Via GlobeNewswire

Frequently Asked Questions

Is Unicycive Therapeutics, Inc. - Common Stock publicly traded?
Yes, Unicycive Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Unicycive Therapeutics, Inc. - Common Stock trade on?
Unicycive Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Unicycive Therapeutics, Inc. - Common Stock?
The ticker symbol for Unicycive Therapeutics, Inc. - Common Stock is UNCY on the Nasdaq Stock Market
What is the current price of Unicycive Therapeutics, Inc. - Common Stock?
The current price of Unicycive Therapeutics, Inc. - Common Stock is 4.160
When was Unicycive Therapeutics, Inc. - Common Stock last traded?
The last trade of Unicycive Therapeutics, Inc. - Common Stock was at 08/29/25 10:50 AM ET
What is the market capitalization of Unicycive Therapeutics, Inc. - Common Stock?
The market capitalization of Unicycive Therapeutics, Inc. - Common Stock is 60.35M
How many shares of Unicycive Therapeutics, Inc. - Common Stock are outstanding?
Unicycive Therapeutics, Inc. - Common Stock has 60M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.